Asthma and lower airway disease
An ex vivo model of severe asthma using reconstituted human bronchial epithelium

https://doi.org/10.1016/j.jaci.2012.01.073Get rights and content

Background

Structural changes to the airways are features of severe asthma. The bronchial epithelium facilitates this remodeling process. Learning about the changes that develop in the airway epithelium could improve our understanding of asthma pathogenesis and lead to new therapeutic approaches.

Objective

We sought to determine the feasibility and relevance of air-liquid interface cultures of bronchial epithelium derived from endobronchial biopsy specimens of patients with different severities of asthma for studying the airway epithelium.

Methods

Human bronchial epithelial cells derived from endobronchial biopsy specimens of patients with mild and severe asthma were maintained in culture for 21 days in an air-liquid interface to reproduce a fully differentiated airway epithelium. Initially, features of remodeling that included epithelial and subepithelial layers, as well as mucus production, were assessed in paraffin-embedded endobronchial biopsy specimens to evaluate morphologic characteristics of asthmatic patients’ epithelia. Ex vivo differentiated epithelia were then analyzed for morphology and function based on ultrastructural analysis, IL-8 release, lipoxin A4 generation, mucin production, and lipoxygenase gene expression.

Results

Morphologic and inflammatory imbalances initially observed in endobronchial biopsy specimens obtained from patients with severe or mild asthma persisted in the air-liquid interface reconstituted epithelium throughout the differentiation process to 21 days. Epithelium from patients with severe asthma produced greater levels of mucin, released more IL-8, and produced lower levels of lipoxin A4 than that from patients with mild asthma. Expression of 15-lipoxygenase 2 was increased in epithelium from patients with severe asthma, whereas expression levels of MUC5AC, MUC5B, 5-lipoxygenase, and 15-lipoxygeanse 1 were similar to those of patients with mild asthma.

Conclusion

Ex vivo cultures of fully differentiated bronchial epithelium from endobronchial biopsy specimens maintain inherent phenotypic differences specifically related to the severity of asthma.

Section snippets

Methods

Additional details are provided in the Methods section in this article’s Online Repository at www.jacionline.org.

Patients with mild (n = 7) and severe (n = 12) asthma were recruited at the Arnaud de Villeneuve Hospital, Montpellier, France. Asthma was diagnosed based on the presence of clinical features consistent with asthma and objective measures of variable airflow obstruction investigated 15 minutes before bronchoscopy (improvement in FEV1 of ≥15% after inhalation of 200 μg of salbutamol).

Demographic data

Bronchial biopsy specimens were obtained from 19 subjects (7 with mild and 12 with severe asthma). Demographic characteristics are reported in Table I. Patients with severe asthma had greater airflow impairment (FEV1 percentage) than those with mild asthma, and their symptoms were uncontrolled (daily symptoms and exacerbation rate) despite treatment. Biopsy specimens were analyzed from 5 control subjects (ie, no asthma, no allergies, nonsmokers, with normal results from chest radiographs and

Discussion

We developed air-liquid interface cultures of bronchial epithelial cells and demonstrated that they maintained characteristics specifically associated with mild and severe asthma. Functional and morphologic analyses of these cultures revealed epithelial differences associated with disease severity. Samples from patients with severe asthma differed in mucus production, cytokine production (sustained IL-8 release), and resolution mechanisms (a defect in LXA4 production associated with

References (40)

  • S.E. Wenzel et al.

    Update in asthma 2005

    Am J Respir Crit Care Med

    (2006)
  • P. Godard et al.

    Costs of asthma are correlated with severity: a 1-yr prospective study

    Eur Respir J

    (2002)
  • S.E. Wenzel et al.

    Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

    Am J Respir Crit Care Med

    (1999)
  • J. Bousquet et al.

    Asthma. From bronchoconstriction to airways inflammation and remodeling

    Am J Respir Crit Care Med

    (2000)
  • O. Haworth et al.

    Endogenous lipid mediators in the resolution of airway inflammation

    Eur Respir J

    (2007)
  • P. Chanez

    Severe asthma is an epithelial disease

    Eur Respir J

    (2005)
  • J.V. Fahy

    Remodeling of the airway epithelium in asthma

    Am J Respir Crit Care Med

    (2001)
  • L. Cohen et al.

    Epithelial cell proliferation contributes to airway remodeling in severe asthma

    Am J Respir Crit Care Med

    (2007)
  • C.L. Ordonez et al.

    Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression

    Am J Respir Crit Care Med

    (2001)
  • J.A. Voynow et al.

    Regulation of mucin genes in chronic inflammatory airway diseases

    Am J Respir Cell Mol Biol

    (2006)
  • Cited by (68)

    • Asthmatic bronchial smooth muscle increases rhinovirus replication within the bronchial epithelium

      2022, Cell Reports
      Citation Excerpt :

      Severe asthma, defined according to the last ATS/ERS (American Thoracic Society/European Respiratory Society) task force, affects 3% to 5% of all person with asthma but is responsible for a large proportion of resource expenditure (Chung et al., 2014). Histologically, bronchi from persons with severe asthma have been characterized by various features of remodeling-associated bronchial epithelial abnormalities, such as metaplasia, thickened epithelium and reticular basement membrane, goblet cell hyperplasia or mucus hypersecretion (Gras et al., 2012), and increased bronchial smooth muscle (BSM) mass (Trian et al., 2007). Functionally, BSM remodeling indicates a poor prognosis in asthma, since an increased BSM mass is associated with decreased lung function (Kaminska et al., 2009) and an increased exacerbation rate (Girodet et al., 2016).

    View all citing articles on Scopus

    Disclosure of potential conflict of interest: P. Chanez is a consultant for Amgen, AstraZeneca, Centocor, Chiesi, GlaxoSmithKline, MSD, Novartis, and Nycomed and has received research support from Centocor. The rest of the authors declare that they have no relevant conflicts of interest.

    View full text